vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $140.7M, roughly 1.5× Purple Innovation, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -2.3%, a 5.0% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 9.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-7.8M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 8.3%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
IRTC vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $140.7M |
| Net Profit | $5.6M | $-3.2M |
| Gross Margin | 70.9% | 41.9% |
| Operating Margin | 1.1% | -1.6% |
| Net Margin | 2.7% | -2.3% |
| Revenue YoY | 27.1% | 9.1% |
| Net Profit YoY | 518.5% | 62.1% |
| EPS (diluted) | $0.18 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $140.7M | ||
| Q3 25 | $192.9M | $118.8M | ||
| Q2 25 | $186.7M | $105.1M | ||
| Q1 25 | $158.7M | $104.2M | ||
| Q4 24 | $164.3M | $129.0M | ||
| Q3 24 | $147.5M | $118.6M | ||
| Q2 24 | $148.0M | $120.3M | ||
| Q1 24 | $131.9M | $120.0M |
| Q4 25 | $5.6M | $-3.2M | ||
| Q3 25 | $-5.2M | $-11.7M | ||
| Q2 25 | $-14.2M | $-17.3M | ||
| Q1 25 | $-30.7M | $-19.1M | ||
| Q4 24 | $-1.3M | $-8.5M | ||
| Q3 24 | $-46.2M | $-39.2M | ||
| Q2 24 | $-20.1M | $27.0K | ||
| Q1 24 | $-45.7M | $-50.2M |
| Q4 25 | 70.9% | 41.9% | ||
| Q3 25 | 71.1% | 42.8% | ||
| Q2 25 | 71.2% | 35.9% | ||
| Q1 25 | 68.8% | 39.4% | ||
| Q4 24 | 70.0% | 42.9% | ||
| Q3 24 | 68.8% | 29.7% | ||
| Q2 24 | 69.9% | 40.7% | ||
| Q1 24 | 66.3% | 34.8% |
| Q4 25 | 1.1% | -1.6% | ||
| Q3 25 | -4.4% | -10.2% | ||
| Q2 25 | -10.0% | -13.5% | ||
| Q1 25 | -20.5% | -13.9% | ||
| Q4 24 | -2.5% | -6.0% | ||
| Q3 24 | -34.1% | -39.5% | ||
| Q2 24 | -15.5% | -12.1% | ||
| Q1 24 | -28.9% | -19.3% |
| Q4 25 | 2.7% | -2.3% | ||
| Q3 25 | -2.7% | -9.9% | ||
| Q2 25 | -7.6% | -16.5% | ||
| Q1 25 | -19.3% | -18.4% | ||
| Q4 24 | -0.8% | -6.6% | ||
| Q3 24 | -31.3% | -33.1% | ||
| Q2 24 | -13.6% | 0.0% | ||
| Q1 24 | -34.6% | -41.8% |
| Q4 25 | $0.18 | $0.03 | ||
| Q3 25 | $-0.16 | $0.11 | ||
| Q2 25 | $-0.44 | $0.16 | ||
| Q1 25 | $-0.97 | $0.18 | ||
| Q4 24 | $-0.03 | $0.08 | ||
| Q3 24 | $-1.48 | $0.36 | ||
| Q2 24 | $-0.65 | $0.00 | ||
| Q1 24 | $-1.47 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $152.7M | $-29.7M |
| Total Assets | $1.0B | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $24.3M | ||
| Q3 25 | $565.2M | $32.4M | ||
| Q2 25 | $545.5M | $34.2M | ||
| Q1 25 | $520.6M | $21.6M | ||
| Q4 24 | $535.6M | $29.0M | ||
| Q3 24 | $522.0M | $23.4M | ||
| Q2 24 | $561.5M | $23.4M | ||
| Q1 24 | $569.1M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $152.7M | $-29.7M | ||
| Q3 25 | $121.9M | $-26.9M | ||
| Q2 25 | $103.7M | $-15.6M | ||
| Q1 25 | $86.7M | $1.3M | ||
| Q4 24 | $90.9M | $20.2M | ||
| Q3 24 | $71.8M | $28.0M | ||
| Q2 24 | $99.2M | $66.4M | ||
| Q1 24 | $90.3M | $65.5M |
| Q4 25 | $1.0B | $296.3M | ||
| Q3 25 | $995.2M | $302.1M | ||
| Q2 25 | $964.0M | $303.8M | ||
| Q1 25 | $926.1M | $293.8M | ||
| Q4 24 | $931.4M | $307.8M | ||
| Q3 24 | $909.7M | $309.3M | ||
| Q2 24 | $919.2M | $362.1M | ||
| Q1 24 | $909.8M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $-5.8M |
| Free Cash FlowOCF − Capex | $14.5M | $-7.8M |
| FCF MarginFCF / Revenue | 6.9% | -5.5% |
| Capex IntensityCapex / Revenue | 5.6% | 1.4% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $-5.8M | ||
| Q3 25 | $34.9M | $-968.0K | ||
| Q2 25 | $27.7M | $-4.0M | ||
| Q1 25 | $-7.9M | $-23.1M | ||
| Q4 24 | $19.2M | $6.8M | ||
| Q3 24 | $24.3M | $1.1M | ||
| Q2 24 | $11.8M | $-8.9M | ||
| Q1 24 | $-52.0M | $-16.8M |
| Q4 25 | $14.5M | $-7.8M | ||
| Q3 25 | $20.1M | $-1.8M | ||
| Q2 25 | $17.3M | $-7.0M | ||
| Q1 25 | $-17.3M | $-25.3M | ||
| Q4 24 | $12.4M | $5.7M | ||
| Q3 24 | $15.5M | $101.0K | ||
| Q2 24 | $3.4M | $-11.0M | ||
| Q1 24 | $-61.8M | $-19.9M |
| Q4 25 | 6.9% | -5.5% | ||
| Q3 25 | 10.4% | -1.5% | ||
| Q2 25 | 9.3% | -6.6% | ||
| Q1 25 | -10.9% | -24.3% | ||
| Q4 24 | 7.5% | 4.4% | ||
| Q3 24 | 10.5% | 0.1% | ||
| Q2 24 | 2.3% | -9.2% | ||
| Q1 24 | -46.8% | -16.5% |
| Q4 25 | 5.6% | 1.4% | ||
| Q3 25 | 7.7% | 0.7% | ||
| Q2 25 | 5.6% | 2.8% | ||
| Q1 25 | 5.9% | 2.2% | ||
| Q4 24 | 4.2% | 0.8% | ||
| Q3 24 | 6.0% | 0.9% | ||
| Q2 24 | 5.7% | 1.7% | ||
| Q1 24 | 7.4% | 2.5% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
